SCHEMBL7343161

SCHEMBL7343161

CC(C)[C@H](NC(=O)OCc1ccccn1)C(=O)NC(Cc1ccccc1)C(O)C(O)C(Cc1ccccc1)NC(=O)[C@@H](NC(=O)OCc1ccccn1)C(C)C

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.69
CTSD P07339 5/20 0.60
SMN1; SMN2 Q16637 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
MAPT P10636 1/20 0.49
TSHR P16473 1/20 0.49
CASP3 P42574 1/20 0.47
CASP7 P55210 1/20 0.47
NPC1 O15118 1/20 0.47
LMNA P02545 1/20 0.47
RAB9A P51151 1/20 0.47
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
REN P00797 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6447680 1.00 CA2 (0.69) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6445023 1.00 CA2 (0.69) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6449063 1.00 CA2 (0.69) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL9227910 1.00 CA2 (0.69) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7275899 0.98 CA2 (0.66) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7270130 0.96 CA2 (0.64) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7428656 0.94 CA2 (0.62) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7334911 0.94 CA2 (0.62) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL7330979 0.93 CA2 (0.61) CA2CTSDSMN1; SMN2CYP1A2CYP2D6
SCHEMBL6449444 0.93 CA2 (0.61) CA2CTSDREN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed